Search for: "Par Pharmaceutical, Inc." Results 1 - 20 of 171
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
In the case at issue, the appellant, Shopify Inc., appealed the decision of the GC T‑222/21, SHOPPI (already commented here), alleging infringement of Article 53(1) of EUTM Regulation no. 207/2009, in conjunction with Article 8(1)(b). [read post]
9 Jan 2023, 9:01 pm by renholding
Walgreens After more than seven years of litigation, Walgreens, Inc. [read post]
5 Jan 2023, 2:22 pm by Kevin LaCroix
The settlement ranks among the five largest securities settlements ever paid by a pharmaceutical manufacturer. [read post]
18 Aug 2022, 11:39 am by Eileen McDermott
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
18 Aug 2022, 11:39 am by Eileen McDermott
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
4 Jan 2022, 10:33 am by Cinthia Macie
  A Pennsylvania federal judge ordered California to pay nearly $80,000 in legal fees to Par Pharmaceutical Inc for failing to comply with discovery obligations in multidistrict litigation alleging a broad price-fixing conspiracy for generic drugs. [read post]
4 Jan 2022, 10:33 am by Cinthia Macie
  A Pennsylvania federal judge ordered California to pay nearly $80,000 in legal fees to Par Pharmaceutical Inc for failing to comply with discovery obligations in multidistrict litigation alleging a broad price-fixing conspiracy for generic drugs. [read post]
16 Sep 2021, 12:57 pm by Simmons Hanly Conroy
Suffolk and Nassau Counties will each receive $13.85 million in combined settlements from Endo and its subsidiary Par Pharmaceutical, Inc. [read post]
29 Nov 2020, 9:59 pm by Patent Docs
This truism was the basis for the Federal Circuit affirming the District Court's decision against a generic drug producer in its recent decision in Par Pharmaceutical, Inc. v. [read post]
31 Jul 2020, 4:48 am
Complete Business Solutions Group Inc. d/b/a/ Par Funding et al. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan… [read post]
13 Jun 2019, 11:24 am by Steven Cohen
Facts:  This case (Par Pharmaceutical, Inc. et al v. [read post]
15 Apr 2019, 7:19 pm by Scott McKeown
Par Pharmaceutical Inc., Nos. 14-1289-RGA, 14-1494-RGA, 15-0078-RGA (D. [read post]
9 Sep 2018, 10:25 am by Patent Docs
Par Pharmaceutical, Inc. v. [read post]